We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
-1.89%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$48.4B
AUM Growth
+$1.38B
(+2.9%)
Cap. Flow
+$2.75B
Cap. Flow
% of AUM
5.68%
Top 10 Holdings %
Top 10 Hldgs %
14.42%
Holding
2,432
New
254
Increased
1,140
Reduced
904
Closed
123
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Hawaiian Electric Industries
HE
|
+$139M |
| 2 |
GE Aerospace
GE
|
+$128M |
| 3 |
NVIDIA
NVDA
|
+$100M |
| 4 |
Citizens Financial Group
CFG
|
+$99M |
| 5 |
Molson Coors Class B
TAP
|
+$97.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CF Industries
CF
|
+$89.6M |
| 2 |
Booking.com
BKNG
|
+$82.6M |
| 3 |
Domino's
DPZ
|
+$81.9M |
| 4 |
Apple
AAPL
|
+$81.9M |
| 5 |
American International
AIG
|
+$75.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.29% |
| 2 | Healthcare | 13.45% |
| 3 | Consumer Discretionary | 13.42% |
| 4 | Industrials | 12.23% |
| 5 | Financials | 11.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2276
CorMedix
CRMD
$591M
| $57.7K | ﹤0.01% |
+15,585
| New | +$62K |
|
2277
FuelCell Energy
FCEL
$1.59B
| $57.5K | ﹤0.01% |
1,498
+817
| +120% | +$42.6K |
|
2278
DocGo
DCGO
$56.8M
| $57.4K | ﹤0.01% |
10,772
-92
| -0.8% | -$747 |
|
2279
Archer Aviation
ACHR
$4.78B
| $57.2K | ﹤0.01% |
+11,302
| New | +$64.8K |
|
2280
Cue Biopharma
CUE
$110M
| $54.9K | ﹤0.01% |
+796
| New | +$77.7K |
|
2281
Information Services Group
III
$251M
| $54.3K | ﹤0.01% |
12,405
-1,455
| -10% | -$7.27K |
|
2282
Veritone
VERI
$134M
| $52.4K | ﹤0.01% |
20,317
-28,891
| -59% | -$95.9K |
|
2283
Harvard Bioscience
HBIO
$28.8M
| $50.5K | ﹤0.01% |
+1,176
| New | +$54.3K |
|
2284
BioVie
BIVI
$8.3M
| $50.4K | ﹤0.01% |
+148
| New | +$57.8K |
|
2285
MaxCyte
MXCT
$130M
| $49.5K | ﹤0.01% |
+15,864
| New | +$63.8K |
|
2286
Smartbird Inc
BIRD
$22.7M
| $49.1K | ﹤0.01% |
2,212
+460
| +26% | +$12.4K |
|
|
ORGN
2287
DELISTED
Origin Materials
ORGN
| $48.2K | ﹤0.01% |
+1,254
| New | +$98.5K |
|
|
BLUE
2288
DELISTED
bluebird bio
BLUE
| $47K | ﹤0.01% |
774
-3,106
| -80% | -$218K |
|
2289
Lyell Immunopharma
LYEL
$351M
| $43.5K | ﹤0.01% |
+1,479
| New | +$70.2K |
|
2290
Microvision
MVIS
$88.5M
| $43.3K | ﹤0.01% |
+1,319
| New | +$60.4K |
|
2291
Ginkgo Bioworks
DNA
$515M
| $42.4K | ﹤0.01% |
+587
| New | +$46.9K |
|
|
CANO
2292
DELISTED
Cano Health, Inc.
CANO
| $42.1K | ﹤0.01% |
+1,659
| New | +$136K |
|
2293
Tenaya Therapeutics
TNYA
$165M
| $37.6K | ﹤0.01% |
+14,745
| New | +$61.7K |
|
2294
Energy Vault
NRGV
$605M
| $36.7K | ﹤0.01% |
14,397
-201,796
| -93% | -$604K |
|
2295
TeraWulf
WULF
$8.08B
| $36.7K | ﹤0.01% |
+29,110
| New | +$69K |
|
2296
Summit Therapeutics
SMMT
$11.9B
| $36K | ﹤0.01% |
+19,225
| New | +$36.7K |
|
2297
Cadiz
CDZI
$279M
| $35.9K | ﹤0.01% |
10,859
| – | – |
|
2298
Seres Therapeutics
MCRB
$50.2M
| $35.8K | ﹤0.01% |
752
-233
| -24% | -$17.8K |
|
2299
Lexicon Pharmaceuticals
LXRX
$1.07B
| $32.2K | ﹤0.01% |
29,558
+1,501
| +5% | +$2.63K |
|
2300
Gevo
GEVO
$388M
| $25.9K | ﹤0.01% |
+21,765
| New | +$32.2K |
|
Similar funds
VGA
AQR Capital Management's Q3 2023 Portfolio in Review
As of Q3 2023, AQR Capital Management held 2,432 positions worth $48.4B, up 2.9% from $47B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
AQR Capital Management deployed $2.75B of net new capital in Q3 2023, opening 254 new positions and adding to 1,140 existing holdings. Its largest new stake was Vanguard FTSE Developed Markets ETF: 624,491 shares worth $27.3M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was CF Industries, an estimated $89.6M trimmed.
- AQR Capital Management's largest Q3 2023 buy was Vanguard FTSE Developed Markets ETF: 624,491 shares worth $27.3M.
- AQR Capital Management added most to Hawaiian Electric Industries in Q3 2023, an estimated $139M increase.
- AQR Capital Management's biggest Q3 2023 reduction was CF Industries, cutting an estimated $89.6M.
- AQR Capital Management fully exited Univar Solutions Inc. in Q3 2023, selling an estimated $60.5M.
- AQR Capital Management's ten largest holdings make up 14% of its $48.4B portfolio in Q3 2023.
- AQR Capital Management opened 254 new positions and closed 123 in Q3 2023.
- AQR Capital Management's portfolio value rose 2.9% quarter-over-quarter to $48.4B.
Based on AQR Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.